Feature | March 29, 2012

Telemedicine Improves Hypertension Medication Management

Continuous patient reporting via Internet may promote better blood pressure control

March 29, 2012 — Internet-based telemedicine systems appear to lead to more appropriate and effective pharmacotherapy, better blood pressure control and an overall reduction in cardiovascular risk compared to conventional, periodic office visits, according to research presented this week at the American College of Cardiology (ACC) Annual Scientific Session in Chicago.

Patients who reported blood pressure readings more frequently via a Web-based portal received more timely treatment decisions and medication adjustments from their healthcare team compared to a control group of hypertensive patients who had routine office visits. These findings have important implications for clinical practice given that – aside from lifestyle changes – antihypertensive medications are the most effective way to help patients lower their blood pressure. As many as 65 million American adults have high blood pressure, and roughly 74 percent take medication for it, according to the Centers for Disease Control and Prevention.

“The ongoing monitoring and reporting of blood pressure levels seems to bring about important changes in physician prescribing habits, which we think ultimately benefits patients,” said Val Rakita, M.D., internal medicine resident at Temple University Hospital and the study’s co-investigator. “Based on our findings, physicians appear to prescribe more blood pressure medications for those patients who continue to have high blood pressure despite the medications they are on. In fact, in one subset of patients, not only did we find they were prescribed more blood pressure medications, it also actually led to a larger blood pressure reduction compared to all other groups.”

In this study, patients from two large medical centers were recruited and randomized to receive either usual care or telemedicine with usual care. Patients in the telemedicine group received counseling on cardiovascular disease risk reduction and were given a home blood pressure cuff and trained on how to use it. They were asked to report their blood pressure, heart rate, weight, steps taken per day and tobacco use twice weekly for six months. By the end of the six-month intervention, medications prescribed to those in the control group were virtually unchanged, while there was a small, but significant, increase in the number of medications ordered (2.2 ± 1.2 to 2.34 ± 1.15, p=0.004) for patients in the telemedicine group.

Rakita says that prescribing more medication in the telemedicine group did not signify over-treatment, but was a reflection of more timely decisions to increase and/or adjust medications based on patient self-monitoring and reporting.

Unlike other types of telemedicine, which may include telephone interactions, this study looked at an Internet-based system that supported ongoing communication between patients and healthcare providers.

“This allows for greater convenience for both sides and most likely led to the better results,” Rakita said. “High blood pressure is one of the most important risk factors for cardiovascular disease, which is the number one cause of death in America. Employing an Internet-based patient-physician communication system that can help lower blood pressure could make it possible to reduce patients’ cardiovascular risk.”

This was a secondary analysis of a telemedicine trial of 241 patients with uncontrolled hypertension (BP?150/90 mmHg). More than half of study participants (56.8 percent) were taking one or two blood pressure-lowering medications at the start of the study. The initial average blood pressure was 156/89±14/11 among all patients. All patients had baseline and six-month follow-up visits. Monthly reports on blood pressure and treatment guidelines were provided to both the patient and physician in the telemedicine group.

Although there was no significant difference in the decrease in blood pressure between the two groups overall, the primary group of nondiabetic patients using telemedicine was found to have lower blood pressure compared to all other groups. Rakita said it is reasonable to believe that the use of additional blood pressure medications in the telemedicine group would have translated to an associated drop in blood pressure in these patients had they been followed for a longer period of time.

“The goal of telemedicine is to reduce disease and the burden on the healthcare system in a cost-effective way,” he said. “By showing that a relatively low-cost, Internet-based telemedicine system can change physicians’ prescribing habits and perhaps [lower] blood pressures, this can lead to obvious benefits to patients and the healthcare system.”

This study was funded by the Agency for Healthcare Research and Quality.

For more information: www.ACC.org

Related Content

News | Heart Failure| October 02, 2015
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the...
Tryton Side Branch Stent, clinical trial results, Catheterization and Cardiovascular Interventions

Tryton Side Branch Stent image courtesy of Tryton Medical

News | Stents Bifurcation| October 02, 2015
October 2, 2015 — Tryton Medical Inc.
Brilinta, 60 mg dose available, U.S. pharmacies
Technology | Antiplatelet and Anticoagulation Therapies| October 02, 2015
AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies. On Sept. 3, 2015,...
Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular

News | Peripheral Arterial Disease (PAD)| October 01, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and...
Johns Hopkins, sticky gel, stem cells, rat hearts, heart attacks

Hydrogel applied to beating rat hearts improves stem cell uptake by the heart muscle and speeds up tissue healing after heart attack. Image courtesy of Johns Hopkins Medicine.

News | Stem Cell Therapies| September 29, 2015
A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and...
News | Cath Lab| September 29, 2015
The Innovation Institute announced that Boston Scientific has signed an agreement to become the founding medical device...
Eluvia drug-eluting vascular stent system, 12-month primary patency, Boston Scientific, MAJESTIC trial, CIRSE

Image courtesy of Boston Scientific

News | Stents Peripheral| September 28, 2015
New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific Eluvia drug-eluting...
predicting arrhythmias, mcgill university, alternans patterns
News | EP Lab| September 28, 2015
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a...
News | Antiplatelet and Anticoagulation Therapies| September 25, 2015
The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial to test the safety...
Medisafe, medication management, mHealth platform, blood pressure study, hypertension, adherence
News | Hypertension| September 25, 2015
Medisafe, an mHealth platform for medication management, announced the results of its blood pressure study, which...
Overlay Init